These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
879 related items for PubMed ID: 19423196
1. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines. Chhabria MT, Jani MH. Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196 [Abstract] [Full Text] [Related]
4. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines. Trivedi A, Dodiya D, Surani J, Jarsania S, Mathukiya H, Ravat N, Shah V. Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851 [Abstract] [Full Text] [Related]
5. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents. Agarwal A, Srivastava K, Puri SK, Sinha S, Chauhan PM. Bioorg Med Chem Lett; 2005 Dec 01; 15(23):5218-21. PubMed ID: 16171994 [Abstract] [Full Text] [Related]
6. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides. Fassihi A, Azadpour Z, Delbari N, Saghaie L, Memarian HR, Sabet R, Alborzi A, Miri R, Pourabbas B, Mardaneh J, Mousavi P, Moeinifard B, Sadeghi-Aliabadi H. Eur J Med Chem; 2009 Aug 01; 44(8):3253-8. PubMed ID: 19371979 [Abstract] [Full Text] [Related]
7. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents. Alegaon SG, Alagawadi KR, Sonkusare PV, Chaudhary SM, Dadwe DH, Shah AS. Bioorg Med Chem Lett; 2012 Mar 01; 22(5):1917-21. PubMed ID: 22325950 [Abstract] [Full Text] [Related]
8. Synthesis and antitubercular screening of imidazole derivatives. Pandey J, Tiwari VK, Verma SS, Chaturvedi V, Bhatnagar S, Sinha S, Gaikwad AN, Tripathi RP. Eur J Med Chem; 2009 Aug 01; 44(8):3350-5. PubMed ID: 19272678 [Abstract] [Full Text] [Related]
9. Novel dihydropyrimidines as a potential new class of antitubercular agents. Trivedi AR, Bhuva VR, Dholariya BH, Dodiya DK, Kataria VB, Shah VH. Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6100-2. PubMed ID: 20813528 [Abstract] [Full Text] [Related]
10. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D, Manetti F, Radi M, Bechi B, Pagano M, De Logu A, Meleddu R, Saddi M, Botta M. Bioorg Med Chem; 2009 Aug 01; 17(15):5716-21. PubMed ID: 19581099 [Abstract] [Full Text] [Related]
11. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents. Bacelar AH, Carvalho MA, Proença MF. Eur J Med Chem; 2010 Jul 01; 45(7):3234-9. PubMed ID: 20416983 [Abstract] [Full Text] [Related]
12. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q, Luo H, Chen Y, Wang T, Yao Q. Bioorg Med Chem Lett; 2009 Sep 15; 19(18):5372-5. PubMed ID: 19682895 [Abstract] [Full Text] [Related]
13. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models. Srivastav NC, Rai D, Tse C, Agrawal B, Kunimoto DY, Kumar R. J Med Chem; 2010 Aug 26; 53(16):6180-7. PubMed ID: 20718497 [Abstract] [Full Text] [Related]
14. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Nayyar A, Monga V, Malde A, Coutinho E, Jain R. Bioorg Med Chem; 2007 Jan 15; 15(2):626-40. PubMed ID: 17107805 [Abstract] [Full Text] [Related]
15. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis. Moura KC, Carneiro PF, Pinto Mdo C, da Silva JA, Malta VR, de Simone CA, Dias GG, Jardim GA, Cantos J, Coelho TS, da Silva PE, da Silva EN. Bioorg Med Chem; 2012 Nov 01; 20(21):6482-8. PubMed ID: 23000294 [Abstract] [Full Text] [Related]
16. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives. Gadad AK, Noolvi MN, Karpoormath RV. Bioorg Med Chem; 2004 Nov 01; 12(21):5651-9. PubMed ID: 15465343 [Abstract] [Full Text] [Related]
17. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives. Trivedi A, Vaghasiya S, Dholariya B, Dodiya D, Shah V. J Enzyme Inhib Med Chem; 2010 Dec 01; 25(6):893-9. PubMed ID: 21054238 [Abstract] [Full Text] [Related]
18. Multi-component synthesis of dihydropyrimidines by iodine catalyst at ambient temperature and in-vitro antimycobacterial activity. Zalavadiya P, Tala S, Akbari J, Joshi H. Arch Pharm (Weinheim); 2009 Aug 01; 342(8):469-75. PubMed ID: 19565601 [Abstract] [Full Text] [Related]
19. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlén A, Larhed M. Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4790-3. PubMed ID: 19560924 [Abstract] [Full Text] [Related]
20. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M, Bakken V, Gundersen LL. Bioorg Med Chem; 2009 Sep 15; 17(18):6512-6. PubMed ID: 19709890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]